Ian Qureshi

845 total citations
8 papers, 714 citations indexed

About

Ian Qureshi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Ian Qureshi has authored 8 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Physiology. Recurrent topics in Ian Qureshi's work include Nitric Oxide and Endothelin Effects (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). Ian Qureshi is often cited by papers focused on Nitric Oxide and Endothelin Effects (2 papers), Cardiac Ischemia and Reperfusion (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). Ian Qureshi collaborates with scholars based in United States, Italy and France. Ian Qureshi's co-authors include Anindita Das, Fadi N. Salloum, Rakesh C. Kukreja, Nicholas N Hoke, Antonio Abbate, Paromita Raha, Scott Thomas, Pamela N. Münster, Kenneth T. Thurn and Giuseppe Biondi‐Zoccai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Ian Qureshi

8 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Qureshi United States 7 402 239 117 104 91 8 714
Yoshitaka Minami Japan 14 498 1.2× 236 1.0× 278 2.4× 62 0.6× 82 0.9× 31 1.1k
Emily Harris United States 10 433 1.1× 123 0.5× 38 0.3× 131 1.3× 124 1.4× 60 852
Felix Mehrhof Germany 10 225 0.6× 303 1.3× 35 0.3× 39 0.4× 53 0.6× 23 630
Daniel J. Herr United States 16 307 0.8× 133 0.6× 48 0.4× 45 0.4× 82 0.9× 41 701
Daisuke Ito Japan 14 573 1.4× 66 0.3× 135 1.2× 107 1.0× 291 3.2× 48 1.2k
Johanna M. U. Silvola Finland 15 312 0.8× 177 0.7× 86 0.7× 147 1.4× 92 1.0× 22 707
Tianyu Li China 22 430 1.1× 62 0.3× 45 0.4× 131 1.3× 324 3.6× 56 1.2k
Nadine Borg Germany 10 313 0.8× 126 0.5× 150 1.3× 40 0.4× 71 0.8× 11 698

Countries citing papers authored by Ian Qureshi

Since Specialization
Citations

This map shows the geographic impact of Ian Qureshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Qureshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Qureshi more than expected).

Fields of papers citing papers by Ian Qureshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Qureshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Qureshi. The network helps show where Ian Qureshi may publish in the future.

Co-authorship network of co-authors of Ian Qureshi

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Qureshi. A scholar is included among the top collaborators of Ian Qureshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Qureshi. Ian Qureshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Fang, Bruno, Luis Paz‐Ares, Ana Laura Ortega Granados, et al.. (2024). 604 Magrolimab + docetaxel in previously treated patients with metastatic non-small cell lung cancer (NSCLC). Regular and Young Investigator Award Abstracts. A695–A695. 1 indexed citations
2.
Amendola, Beatriz E., Naipy Pérez, Xiaodong Wu, Marco A. Amendola, & Ian Qureshi. (2019). Safety and Efficacy of Lattice Radiotherapy in Voluminous Non-small Cell Lung Cancer. Cureus. 11(3). e4263–e4263. 60 indexed citations
3.
Thurn, Kenneth T., Scott Thomas, Paromita Raha, Ian Qureshi, & Pamela N. Münster. (2013). Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling. Molecular Cancer Therapeutics. 12(10). 2078–2087. 92 indexed citations
4.
Das, Anindita, David Durrant, Clint Mitchell, et al.. (2010). Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proceedings of the National Academy of Sciences. 107(42). 18202–18207. 137 indexed citations
5.
Abbate, Antonio, Fadi N. Salloum, Elena Vecile, et al.. (2008). Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction. Circulation. 117(20). 2670–2683. 302 indexed citations
6.
Salloum, Fadi N., Antonio Abbate, Anindita Das, et al.. (2008). Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. American Journal of Physiology-Heart and Circulatory Physiology. 294(3). H1398–H1406. 93 indexed citations
7.
Straino, Stefania, Fadi N. Salloum, Alfonso Baldi, et al.. (2007). Protective Effects of Parecoxib, a Cyclo-Oxygenase-2 Inhibitor, in Postinfarction Remodeling in the Rat. Journal of Cardiovascular Pharmacology. 50(5). 571–577. 20 indexed citations
8.
Al-khlaiwi, Thamir, Abdulmajeed AlDrees, Erdal Gursoy, et al.. (2005). Estrogen Protects Cardiac Myogenic (H9c2) Rat Cells Against Lethal Heat Shock-Induced Cell Injury. Journal of Cardiovascular Pharmacology. 45(3). 217–224. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Minami Breakdown of academic impact, for papers by Emily Harris Breakdown of academic impact, for papers by Felix Mehrhof Breakdown of academic impact, for papers by Daniel J. Herr Breakdown of academic impact, for papers by Daisuke Ito Breakdown of academic impact, for papers by Johanna M. U. Silvola Breakdown of academic impact, for papers by Tianyu Li Breakdown of academic impact, for papers by Nadine Borg
Rankless by CCL
2026